Dysregulated COMT Expression in Fragile X Syndrome.

[1]  Samir Ruxmohan,et al.  Behavioral Problems in Fragile X Syndrome: A Review of Clinical Management , 2022, Cureus.

[2]  Joseph P. McCleery,et al.  Genetic modifiers in rare disorders: the case of fragile X syndrome , 2020, European journal of human genetics : EJHG.

[3]  K. H. Utami,et al.  Elevated de novo protein synthesis in FMRP-deficient human neurons and its correction by metformin treatment , 2020, Molecular Autism.

[4]  Deborah Chasman,et al.  Identification of FMR1-regulated molecular networks in human neurodevelopment , 2020, Genome research.

[5]  Virginia C. Salo,et al.  Relations between catechol-O-methyltransferase Val158Met genotype and inhibitory control development in childhood. , 2019, Developmental psychobiology.

[6]  M. Mann,et al.  Integrative Analysis Identifies Key Molecular Signatures Underlying Neurodevelopmental Deficits in Fragile X Syndrome , 2019, Biological Psychiatry.

[7]  B. Bardoni,et al.  HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein , 2018, Nucleic acids research.

[8]  Steven Taylor,et al.  Association between COMT Val158Met and psychiatric disorders: A comprehensive meta‐analysis , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[9]  Heather Cody Hazlett,et al.  Fragile X syndrome , 2017, Nature Reviews Disease Primers.

[10]  A. Fresán,et al.  The Role of a Catechol-O-Methyltransferase (COMT) Val158Met Genetic Polymorphism in Schizophrenia: A Systematic Review and Updated Meta-analysis on 32,816 Subjects , 2016, NeuroMolecular Medicine.

[11]  Qi Ding,et al.  Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background , 2014, Behavioural Brain Research.

[12]  B. Kolachana,et al.  Biological Effects of COMT Haplotypes and Psychosis Risk in 22q11.2 Deletion Syndrome , 2014, Biological Psychiatry.

[13]  M. Stanford,et al.  Association of the COMT Met¹⁵⁸ allele with trait impulsivity in healthy young adults. , 2013, Molecular medicine reports.

[14]  Uwe Ohler,et al.  FMR1 targets distinct mRNA sequence elements to regulate protein expression , 2012, Nature.

[15]  D. Licatalosi,et al.  FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.

[16]  H. Rauvala,et al.  Effect of S-COMT deficiency on behavior and extracellular brain dopamine concentrations in mice , 2010, Psychopharmacology.

[17]  C. Freitag,et al.  Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant , 2010, Journal of Neural Transmission.

[18]  J. Waddington,et al.  Exploratory and habituation phenotype of heterozygous and homozygous COMT knockout mice , 2007, Behavioural Brain Research.

[19]  M C O'Donovan,et al.  The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons , 2006, Molecular Psychiatry.

[20]  D. Collier,et al.  The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression , 2006, BMC Medical Genetics.

[21]  Y. Gomita,et al.  Effect of methamphetamine and imipramine on cerebral ischemia-induced hyperactivity in Mongolian gerbils. , 2002, Japanese journal of pharmacology.

[22]  D. Pfaff,et al.  Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Turner.  Fragile X Syndrome: Diagnosis, Treatment and Research , 1997 .